Kontsekova, E., Zilka, N., Kovacech, B., Novak, P., & Novak, M. (2014). First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model. Alzheimers Res Ther.

Kontsekova, Eva, Norbert Zilka, Branislav Kovacech, Petr Novak, and Michal Novak. "First-in-man Tau Vaccine Targeting Structural Determinants Essential for Pathological Tau–tau Interaction Reduces Tau Oligomerisation and Neurofibrillary Degeneration in an Alzheimer’s Disease Model." Alzheimers Res Ther 2014.

Kontsekova, Eva, et al. "First-in-man Tau Vaccine Targeting Structural Determinants Essential for Pathological Tau–tau Interaction Reduces Tau Oligomerisation and Neurofibrillary Degeneration in an Alzheimer’s Disease Model." Alzheimers Res Ther 2014.